Intratect

Human Normal Immunoglobulin, the active ingredient in Intratect, is an Immunoglobulin presented as a solution for injection for intravenous use. It provides passive immunity by supplying pooled IgG antibodies that neutralize pathogens and modulate immune response, and is used in patients with primary or secondary immunodeficiency, as well as in certain autoimmune and inflammatory conditions.

GNH USA supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality and regulatory compliance.

Intratect is an intravenous immunoglobulin used to treat disorders involving immune deficiency or dysregulation. - Primary immunodeficiency diseases: replaces missing antibodies to prevent recurrent infections. - Secondary immunodeficiency (e.g., post‑transplant): provides antibody support to reduce infection risk. - Immune thrombocytopenia (ITP): raises platelet counts and reduces bleeding. - Kawasaki disease: lowers incidence of coronary artery aneurysms. - Chronic inflammatory demyelinating polyneuropathy (CIDP): improves muscle strength and functional ability.

Adverse reactions may occur with intravenous immunoglobulin therapy.

Common Side Effects: - Headache: mild to moderate, often transient. - Fever or chills: typically during or shortly after infusion. - Nausea or vomiting: gastrointestinal discomfort. - Fatigue: feeling of tiredness post‑infusion. - Mild infusion site reactions: erythema or swelling. - Muscle aches: generalized soreness.

Serious or Rare Side Effects: - Aseptic meningitis: severe headache with neck stiffness. - Thromboembolic events: clot formation in vessels. - Acute renal failure: sudden loss of kidney function. - Hemolytic anemia: destruction of red blood cells. - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Severe hypotension: sudden drop in blood pressure during infusion.

Intratect requires careful patient assessment and monitoring. - IgA deficiency screening: avoid severe reactions in IgA‑deficient patients. - Renal function monitoring: assess baseline creatinine and hydration status. - Thrombotic risk evaluation: consider history of clotting disorders. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Storage at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect may interact with other medicines and vaccines.

Major Interactions (Avoid): - Live attenuated vaccines: may cause infection due to immunosuppression. - High‑dose aspirin or anticoagulants: increased bleeding risk during infusion.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as IVIG can affect anticoagulation. - Corticosteroids: heightened infection susceptibility. - Diuretics: risk of renal impairment, monitor fluid balance. - ACE inhibitors: potential additive renal stress. - Other immunoglobulin products: avoid overlapping dosing to prevent overload.